Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 27, 2020 Filed Dec 2, 2020 00:02 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,930 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-060968 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,900 Underlying: Common Stock · 2,930 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 27, 2020 Filed Dec 2, 2020 00:02 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 2,930 | $30.00 | $87,900.00 |
DisclosureSEC source: 0001209191-20-060968 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| November 27, 2020 Filed Dec 2, 2020 00:02 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 2,930 | $1.53 | $4,482.90 |
DisclosureSEC source: 0001209191-20-060968 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,340 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-060538 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,830 Underlying: Common Stock · 2,340 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 2,340 | $27.29 | $63,848.07 |
DisclosureSEC source: 0001209191-20-060538 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. 1,170 shares were sold at $27.2853 and 1,170 shares were sold at $27.2856. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 2,340 | $1.53 | $3,580.20 |
DisclosureSEC source: 0001209191-20-060538 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 22:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001209191-20-058488 · doc4.xml · derivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,333 Underlying: Common Stock · 20,000 shares Expires 2027-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 22:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 20,000 | $0.86 | $17,100.00 |
DisclosureSEC source: 0001209191-20-058488 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,340 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-058002 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,170 Underlying: Common Stock · 2,340 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 2,340 | $26.26 | $61,448.40 |
DisclosureSEC source: 0001209191-20-058002 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 2,340 | $1.53 | $3,580.20 |
DisclosureSEC source: 0001209191-20-058002 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 5, 2020 22:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $1.53 | $7,650.00 |
DisclosureSEC source: 0001209191-20-057160 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 22:00 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,315 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-056681 · doc4.xml · derivative · entry 5 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,611 Underlying: Common Stock · 2,315 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 22:00 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,629 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001209191-20-056681 · doc4.xml · derivative · entry 4 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,778 Underlying: Common Stock · 4,629 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 22:00 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 6,944 | $31.27 | $217,152.77 |
DisclosureSEC source: 0001209191-20-056681 · doc4.xml · nonDerivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 22:00 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 2,315 | $1.58 | $3,646.13 |
DisclosureSEC source: 0001209191-20-056681 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 22:00 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 4,629 | $1.49 | $6,874.07 |
DisclosureSEC source: 0001209191-20-056681 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 23:43 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,805 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-056143 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,510 Underlying: Common Stock · 3,805 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 23:43 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 3,805 | $35.04 | $133,334.81 |
DisclosureSEC source: 0001209191-20-056143 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.0337 to $35.0481, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 23:43 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,805 | $1.53 | $5,821.65 |
DisclosureSEC source: 0001209191-20-056143 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 22:15 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,315 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001209191-20-055604 · doc4.xml · derivative · entry 8 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,129 Underlying: Common Stock · 2,315 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 22:15 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,315 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-055604 · doc4.xml · derivative · entry 7 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,612 Underlying: Common Stock · 2,315 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 22:15 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,870 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-055604 · doc4.xml · derivative · entry 6 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,591 Underlying: Common Stock · 7,870 shares Expires 2028-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 22:15 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $35.59 | $177,951.50 |
DisclosureSEC source: 0001209191-20-055604 · doc4.xml · nonDerivative · entry 5 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 22:15 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $35.42 | $265,656.75 |
DisclosureSEC source: 0001209191-20-055604 · doc4.xml · nonDerivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 22:15 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 2,315 | $5.18 | $11,980.13 |
DisclosureSEC source: 0001209191-20-055604 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 22:15 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 2,315 | $1.58 | $3,646.13 |
DisclosureSEC source: 0001209191-20-055604 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 22:15 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 7,870 | $1.53 | $12,041.10 |
DisclosureSEC source: 0001209191-20-055604 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Nov 5, 2020 22:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-057160 · doc4.xml · derivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,591 Underlying: Common Stock · 5,000 shares Expires 2028-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 21, 2020 Filed Nov 5, 2020 22:00 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $31.44 | $157,209.00 |
DisclosureSEC source: 0001209191-20-057160 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 22:33 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,560 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-054833 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,315 Underlying: Common Stock · 5,560 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 22:33 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 5,560 | $43.03 | $239,236.24 |
DisclosureSEC source: 0001209191-20-054833 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.0249 to $43.0302, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 22:33 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 5,560 | $1.53 | $8,506.80 |
DisclosureSEC source: 0001209191-20-054833 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,315 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-054284 · doc4.xml · derivative · entry 6 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,927 Underlying: Common Stock · 2,315 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,185 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-054284 · doc4.xml · derivative · entry 5 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,461 Underlying: Common Stock · 10,185 shares Expires 2028-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $41.73 | $208,629.00 |
DisclosureSEC source: 0001209191-20-054284 · doc4.xml · nonDerivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $41.76 | $313,166.25 |
DisclosureSEC source: 0001209191-20-054284 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 2,315 | $1.58 | $3,646.13 |
DisclosureSEC source: 0001209191-20-054284 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 10,185 | $1.53 | $15,583.05 |
DisclosureSEC source: 0001209191-20-054284 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:19 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,315 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-053260 · doc4.xml · derivative · entry 5 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,926 Underlying: Common Stock · 2,315 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:19 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,630 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001209191-20-053260 · doc4.xml · derivative · entry 4 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,407 Underlying: Common Stock · 4,630 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:19 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 6,945 | $34.75 | $241,341.53 |
DisclosureSEC source: 0001209191-20-053260 · doc4.xml · nonDerivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:19 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 2,315 | $1.58 | $3,646.13 |
DisclosureSEC source: 0001209191-20-053260 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:19 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 4,630 | $1.49 | $6,875.55 |
DisclosureSEC source: 0001209191-20-053260 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,510 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-052656 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,875 Underlying: Common Stock · 3,510 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 3,510 | $38.00 | $133,380.00 |
DisclosureSEC source: 0001209191-20-052656 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,510 | $1.53 | $5,370.30 |
DisclosureSEC source: 0001209191-20-052656 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,700 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-052221 · doc4.xml · derivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,385 Underlying: Common Stock · 3,700 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,700 | $1.53 | $5,661.00 |
DisclosureSEC source: 0001209191-20-052221 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2020 Filed Sep 23, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,805 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-051679 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,085 Underlying: Common Stock · 3,805 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.